PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $806,000 | -19.7% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,004,000 | -24.0% | 620,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $1,321,000 | -42.4% | 620,000 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $2,294,000 | +397.6% | 620,000 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $461,000 | -4.4% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $482,000 | -14.1% | 620,000 | 0.0% | 0.00% | – |
| Q1 2022 | $561,000 | -88.7% | 620,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $4,966,000 | -4.3% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,189,000 | +24.2% | 620,000 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $4,179,000 | +2.0% | 620,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $4,098,000 | +45433.3% | 620,000 | +21279.3% | 0.01% | – |
| Q4 2017 | $9,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |